Transplantation

News

Repurposed drug could improve HSCT

A medication used to treat joint and skin conditions might also improve allogeneic hematopoietic stem cell transplant (HSCT), according to...

Conference Coverage

Allo-HSCT leads to long-term survival in MF

ATLANTA—One of the largest single-center studies of fludarabine/melphalan-based allogeneic hematopoietic stem cell transplant (allo-HSCT) for...

News

Antibody prevents GVHD in mice

Preclinical research suggests PRO 140, a humanized anti-CCR5 monoclonal antibody, can prevent graft-versus-host disease (GVHD) in mice. Mice that...

Pages